Tom Dumoulin says the Bradley Wiggins/TUE episode 'stinks'
Dutch rider Tom Dumoulin is strongly against the use of drugs such as triamcinolone, and says medications administered via unnecessary TUEs are unfair


Dutchman Tom Dumoulin (Giant-Alpecin) says that Bradley Wiggins’s pre-Tour de France corticosteroid injection "stinks" and that superfluous TUEs are "cheating."
Russian hacker group Fancy Bears published the therapeutic use exemptions (TUEs) of several athletes in the last two weeks using data gained illegally from the World Anti-Doping Agency (WADA) database
Fancy Bears' second data dump showed Wiggins applied for and received permission from the Union Cycliste Internationale (UCI) to inject triamcinolone, a corticosteroid, ahead of the 2011 and 2012 editions of the Tour de France, and ahead of the 2013 Giro d'Italia.
Dumoulin, silver medallist in the Rio 2016 Olympic time trial and compared to Wiggins as a time triallist-cum-classification cyclist, was disgusted by the revelations.
"It is very strange that every time Wiggins took the medication it was in the same period," Dumoulin told Dutch newspaper De Limburger.
>>> Bradley Wiggins: corticosteroid use ‘wasn’t about trying to gain an unfair advantage’
"And injecting? So then you have very bad asthma, different from the normal asthmatic. Or let alone athletes who only have exercise-induced asthma. Apparently Wiggins's injection worked for weeks. If so, then in my opinion, you should sit out of competition for weeks. This thing stinks."
Confessed dopers David Millar, Jorg Jaksche and Michael Rasmussen recently said that the effects of triamcinolone or 'Kenacort' are strong.
"As I said in my book, I took EPO and testosterone patches, and they obviously produce huge differences... Kenacort [triamcinolone], though, was the only one you took and three days later you looked different," Millar told The Telegraph last week.
"You would do all the training but my weight would stick. But if I took Kenacort, 1.5-2kgs would drop off in like a week. And not only would the weight drop off, I would feel stronger."
"No, that's cheating?" Dumoulin said when asked if he would consider applying for such a TUE.
>>> David Millar calls for Bradley Wiggins’s TUE medication to be banned
"I have never applied for a certificate. I once used a puff, but I did not need permission. This controversy of certificates comes up quite often. It is still ingrained in the sport. And I think these are certificates that are already approved in advance. The system works for shit."
"You'd have no hassle [if the TUEs were made public], everyone would know what you're doing, even if it runs counter to medical confidentiality. If it helps us get closer to a clean sport, I'm for it."
Dumoulin would be unable to race with such a certificate if he wanted to. His Giant-Alpecin team is one of seven of the 18 teams who are part of the voluntary Movement for a Credible Cycling (MPCC). They follow stricter rules than WADA and the UCI require. One rule states that a team must pull a rider from competition for eight days if he needs use a corticosteroid for asthma.
Sky and other top teams like Etixx-QuickStep never joined the MPCC.
Wiggins defended his corticosteroid use on Sunday in an interview on BBC One. "This was to cure a medical condition," he said. "This wasn't about trying to find a way to gain an unfair advantage, this was about putting myself back on a level playing field in order to compete at the highest level."
Wiggins is due to retire at the end of this season with only the Abu Dhabi Tour, and the London and Ghent Six-Days on his calendar.
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Gregor Brown is an experienced cycling journalist, based in Florence, Italy. He has covered races all over the world for over a decade - following the Giro, Tour de France, and every major race since 2006. His love of cycling began with freestyle and BMX, before the 1998 Tour de France led him to a deep appreciation of the road racing season.
-
-
Five talking points from stage eleven of the Giro d’Italia 2022
The Cycling Weekly highlights package from the stage which finally saw an Italian win at the home race this year
By Luke Friend • Published
-
Strava acquires injury prevention app Recover Athletics to provide personalised prehab
Evidence-based exercises are claimed to help athletes stay injury-free
By Anna Marie Hughes • Published
-
British Cycling offers Bradley Wiggins 'full support' after allegations of sexual grooming
The governing body has contacted Wiggins after he alleged he was sexually groomed as a 13-year-old
By Ryan Dabbs • Published
-
Bradley Wiggins alleges that he was sexually groomed by a coach as a 13-year-old
Former Tour de France winner says that it "impacted" him as an adult after he "buried" it
By Adam Becket • Published
-
Tom Dumoulin confident altitude training in Tenerife will help Giro d'Italia ambitions: 'I will do the necessary work'
The Dutchman has performed inconsistently in 2022, but still has his sights set on GC victory next month
By Ryan Dabbs • Published
-
Tom Dumoulin doesn't rule out Grand Tour return in 2022
Dutchman will decide on his season at the Jumbo-Visma training camp in mid-December
By Ryan Dabbs • Published
-
Tom Dumoulin runs rapid 10k in hometown of Maastricht
The former Giro d'Italia winner finished second in the event where he averaged 18.3km/h
By Tim Bonville-Ginn • Published
-
Tom Dumoulin trains with Dutch amateurs as he starts cycling again
The Dutchman is back riding two months after being hit by a car and fracturing his wrist
By Ryan Dabbs • Published
-
Bradley Wiggins expresses regret for past behaviour: 'I was never good at handling public fame and adulation'
The 2012 Tour de France winner isn't proud of the public persona he had
By Ryan Dabbs • Published
-
BikeExchange interested in Tom Dumoulin for 2023 'if he wants to carry on with GC ambitions'
Dumoulin will be free at the end of 2022, when his contract with Jumbo-Visma runs out
By Ryan Dabbs • Published